摘要
目的:观察痰热清用于治疗慢性阻塞性肺疾病急性发作期合并呼吸衰竭患者的疗效。方法:收治慢性阻塞性肺疾病急性发作期合并呼吸衰竭患者60例,分为观察组和对照组,对照组行常规有创呼吸支持,抗感染,解痉等综合治疗,观察组在对照组的基础上加用痰热清辅助治疗。比较治疗前后患者有创机械通气时间,血气分析结果以及临床表现的变化。结果:两组治疗后PO2和PCO2均较治疗前改善(P<0.05),治疗后观察组PO2高于对照组(P<0.05),PCO2值低于对照组(P<0.05),观察组治愈率高于对照组(P<0.05),观察组的带机时间较对照组短(P<0.05)。结论:痰热清用于治疗慢性阻塞性肺疾病能有效改善患者肺通气功能,提高临床疗效,是一种值得临床重视的辅助治疗药物。
Objective:To observe the curative effect of Tan Re Qing in the treatment of chronic obstructive pulmonary disease in acute attack combined with respiratory failure.Methods:60 patients with chronic obstructive pulmonary disease in acute attack acute combined with respiratory failure were selected,there were divided into the observation group and the control group.The control group was treated with conventional invasive respiratory support,anti-infection,spasmolysis and other comprehensive treatment;the observation group added Tan Re Qing treatment on the basis of the control group.Invasive mechanical ventilation time,blood gas analysis results and the changes of clinical manifestations of patients before and after treatment were compated.Results:After treatment of the two groups,PO2 and PCO2 were improved than before treatment(P<0.05);after treatment,in the observation group,PO2 was higher than that of the control group(P<0.05),PCO2 was lower than the control group(P<0.05),the cure rate was higher than the control group(P<0.05),the machine time was shorter than the control group(P<0.05).Conclusion:Tan Re Qing in the treatment of chronic obstructive pulmonary disease can effectively improve the pulmonary ventilation function,improve the clinical efficacy,and it is an adjuvant therapy drug which is worthy of clinical attention.
关键词
痰热清注射液
慢性阻塞性肺疾病
呼吸衰竭
血气分析
Tan Re Qing injection
Chronic obstructive pulmonary disease
Respiratory failure
Blood gas analysis
